Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-23

Clinical Trial Update: Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM) [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting completion of a study evaluating clarithromycin for infections caused by non-tuberculous mycobacteria, including Mycobacterium av…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • clarithromycin (clarithromycin)

Snippet

Sponsor: The University of Texas Health Science Center at Tyler | Conditions: Nontuberculous Mycobacteria, Mycobacterium Avium Complex | Phase 4 | Status: COMPLETED